CXCR4 knockdown enhances sensitivity of paclitaxel via the PI3K/Akt/mTOR pathway in ovarian carcinoma.
Zi D, Li Q, Xu CX, Zhou ZW, Song GB, Hu CB, Wen F, Yang HL, Nie L, Zhao X, Tan J, Zhou SF, He ZX.
Zi D, et al. Among authors: wen f.
Aging (Albany NY). 2022 Jun 9;14(11):4673-4698. doi: 10.18632/aging.203241. Epub 2022 Jun 9.
Aging (Albany NY). 2022.
PMID: 35681259
Free PMC article.